Contact this trialFirst, we need to learn more about you.
Histone Deacetylase Inhibitor
Tazemetostat + Belinostat for Lymphoma
Recruiting1 awardPhase 1
New Brunswick, New Jersey
This trial tests a combo of drugs to treat lymphomas that have relapsed or resisted treatment. The drugs may stop tumor growth by blocking enzymes needed for cell growth.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service